Your browser doesn't support javascript.
loading
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
Cocco, Emiliano; Benhamida, Jamal; Middha, Sumit; Zehir, Ahmet; Mullaney, Kerry; Shia, Jinru; Yaeger, Rona; Zhang, Liying; Wong, Donna; Villafania, Liliana; Nafa, Khedoudja; Scaltriti, Maurizio; Drilon, Alexander; Saltz, Leonard; Schram, Alison M; Stadler, Zsofia K; Hyman, David M; Benayed, Ryma; Ladanyi, Marc; Hechtman, Jaclyn F.
Afiliación
  • Cocco E; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Benhamida J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Middha S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mullaney K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wong D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Villafania L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nafa K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Scaltriti M; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Drilon A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Saltz L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schram AM; Weill Cornell Medical College, New York, New York.
  • Stadler ZK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Benayed R; Weill Cornell Medical College, New York, New York.
  • Ladanyi M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hechtman JF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Res ; 79(6): 1047-1053, 2019 03 15.
Article en En | MEDLINE | ID: mdl-30643016
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Biomarcadores de Tumor / Proteínas de Fusión Oncogénica / Proteínas Proto-Oncogénicas p21(ras) / Metilación de ADN / Proteínas Proto-Oncogénicas B-raf / Homólogo 1 de la Proteína MutL Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Biomarcadores de Tumor / Proteínas de Fusión Oncogénica / Proteínas Proto-Oncogénicas p21(ras) / Metilación de ADN / Proteínas Proto-Oncogénicas B-raf / Homólogo 1 de la Proteína MutL Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos